Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Microbiota Diversity in Human Colorectal Cancer Tissues Is Associated with Clinicopathological Features.

Wu Y, Shi L, Li Q, Wu J, Peng W, Li H, Chen K, Ren Y, Fu X.

Nutr Cancer. 2019 Mar 7:1-9. doi: 10.1080/01635581.2019.1578394. [Epub ahead of print]

PMID:
30843732
2.

[Comparison of clinicopathological features and prognosis between left-sided colon cancer and right-sided colon cancer].

Gao X, Yu G, Liu P, Hao L, Liu L, Zhang W.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jun 25;20(6):647-653. Chinese.

PMID:
28643309
3.

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.

4.
5.

Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.

Gao JY, Song BR, Peng JJ, Lu YM.

World J Gastroenterol. 2012 Nov 7;18(41):5965-71. doi: 10.3748/wjg.v18.i41.5965.

6.

Microbiota disbiosis is associated with colorectal cancer.

Gao Z, Guo B, Gao R, Zhu Q, Qin H.

Front Microbiol. 2015 Feb 2;6:20. doi: 10.3389/fmicb.2015.00020. eCollection 2015.

7.

Risk clinicopathological factors for lymph node metastasis in poorly differentiated early gastric cancer and their impact on laparoscopic wedge resection.

Huo ZB, Chen SB, Zhang J, Li H, Wu DC, Zhai TS, Luan SF.

World J Gastroenterol. 2012 Nov 28;18(44):6489-93; discussion p. 6492. doi: 10.3748/wjg.v18.i44.6489.

8.

Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.

Lu Y, Jingyan G, Baorong S, Peng J, Xu Y, Cai S.

Cancer Biomark. 2012;11(5):219-26. doi: 10.3233/CBM-2012-00282.

PMID:
23220854
9.

Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer.

Zhu Q, Jin Z, Wu W, Gao R, Guo B, Gao Z, Yang Y, Qin H.

PLoS One. 2014 Mar 6;9(6):e90849. doi: 10.1371/journal.pone.0090849. eCollection 2014.

10.

[Change in location of colorectal cancer in Hungarian patients between 1993-2004].

Fuszek P, Horváth HC, Speer G, Papp J, Haller P, Halász J, Járay B, Székely E, Schaff Z, Papp A, Bursics A, Harsányi L, Lukovich P, Kupcsulik P, Hitre E, Lakatos PL.

Orv Hetil. 2006 Apr 23;147(16):741-6. Hungarian.

PMID:
16711260
11.

Comparative clinicopathological characteristics of colon and rectal T1 carcinoma.

Ichimasa K, Kudo SE, Miyachi H, Kouyama Y, Hayashi T, Wakamura K, Hisayuki T, Kudo T, Misawa M, Mori Y, Matsudaira S, Hidaka E, Hamatani S, Ishida F.

Oncol Lett. 2017 Feb;13(2):805-810. doi: 10.3892/ol.2016.5464. Epub 2016 Dec 6.

12.

Feasibility study on expanded indication for endoscopic submucosal dissection of intramucosal poorly differentiated early gastric cancer.

Li H, Huo ZB, Chen SB, Li H, Wu DC, Zhai TS, Xiao QH, Wang SX, Zhang LL.

World J Gastroenterol. 2016 Aug 7;22(29):6736-41. doi: 10.3748/wjg.v22.i29.6736.

13.

Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?

Bae JM, Rhee YY, Kim KJ, Wen X, Song YS, Cho NY, Kim JH, Kang GH.

Hum Pathol. 2016 Jan;47(1):85-94. doi: 10.1016/j.humpath.2015.09.008. Epub 2015 Sep 25.

PMID:
26520418
14.

[The differences between three distinct locations of colorectal cancers based on clinicopathological characteristics and molecular features].

Li C, Wang Z, Zhao J, Cai S, Xu Y, Liu F.

Zhonghua Yu Fang Yi Xue Za Zhi. 2014 Dec;48(12):1078-82. Chinese.

PMID:
25619220
15.

Tumour-associated and non-tumour-associated microbiota in colorectal cancer.

Flemer B, Lynch DB, Brown JM, Jeffery IB, Ryan FJ, Claesson MJ, O'Riordain M, Shanahan F, O'Toole PW.

Gut. 2017 Apr;66(4):633-643. doi: 10.1136/gutjnl-2015-309595. Epub 2016 Mar 18.

16.

Pure Well-Differentiated Adenocarcinoma Is a Safe Factor for Lymph Node Metastasis in T1 and T2 Colorectal Cancer: A Pilot Study.

Yoshida N, Nakanishi M, Inoue K, Yasuda R, Hirose R, Naito Y, Itoh Y, Arita T, Murayama Y, Kuriu Y, Otsuji E, Yanagisawa A, Ogiso K, Murakami T, Morinaga Y, Konishi E, Inada Y, Kishimoto M.

Gastroenterol Res Pract. 2018 Nov 18;2018:8798405. doi: 10.1155/2018/8798405. eCollection 2018.

17.

TYMS serves as a prognostic indicator to predict the lymph node metastasis in Chinese patients with colorectal cancer.

Lu Y, Zhuo C, Cui B, Liu Z, Zhou P, Lu Y, Wang B.

Clin Biochem. 2013 Oct;46(15):1478-83. doi: 10.1016/j.clinbiochem.2013.06.017. Epub 2013 Jun 25.

PMID:
23810585
18.

[Clinicopathological analysis of lymph node metastasis in colorectal adenocarcinoma].

Zhao XL, Xu Q, Zhang Y, Xing L, Liu HG, Jin YL.

Zhonghua Yi Xue Za Zhi. 2016 Aug 23;96(32):2583-7. doi: 10.3760/cma.j.issn.0376-2491.2016.32.014. Chinese.

PMID:
27596556
19.

[Expression of microRNA-29b in colorectal cancer and its relationship with clinicopathological features].

Ma X, Yuan W, Tang WY, Ma J.

Zhonghua Zhong Liu Za Zhi. 2016 Jun 23;38(6):430-3. doi: 10.3760/cma.j.issn.0253-3766.2016.06.006. Chinese.

PMID:
27346400
20.

The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.

Powell AG, Wallace R, McKee RF, Anderson JH, Going JJ, Edwards J, Horgan PG.

Colorectal Dis. 2012 Dec;14(12):1493-9. doi: 10.1111/j.1463-1318.2012.03048.x.

PMID:
22507826

Supplemental Content

Support Center